Why Some Turn to Mounjaro Over Other Weight Loss Medications
Mounjaro is currently FDA-approved for the treatment of Type 2 diabetes. However, it has the added benefit of helping users lose weight.
Why some prefer Mounjaro for weight loss:
Dual agonist activity: Mounjaro is a dual agonist, meaning that it targets two different hormone receptors: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). GLP-1 and GIP are both hormones that play a role in regulating blood sugar levels and appetite. By targeting both of these receptors, Mounjaro is thought to be more effective for weight loss than other medications that only target one receptor.
Clinical trial results: In a clinical trial, people who took Mounjaro lost an average of 26.6% of their body weight over 84 weeks, while those who took Ozempic lost an average of 22.3% and those who took Wegovy lost an average of 22.9%. These results suggest that Mounjaro may be more effective than semaglutide for weight loss than other GLP-1 agonists.
Tailorable dosing: Mounjaro is available in a variety of doses, so it can be tailored to individual needs. This is important because different people respond differently to weight loss medications.
Tolerability: Mounjaro is relatively well-tolerated, with the most common side effects being mild and gastrointestinal in nature. This is important because people are more likely to stick with a weight loss medication if they do not have severe side effects.
In addition to the above, some people may prefer Mounjaro for weight loss because:
It is a newer medication, which means that it has been more rigorously tested than older medications.
It is injectable, which means that it is absorbed directly into the bloodstream and does not have to pass through the digestive system. This may lead to better weight loss results than with oral medications.
It is associated with other health benefits, such as improved blood sugar control and reduced risk of cardiovascular disease.
However, it is important to note that Mounjaro is a new drug and long-term safety and efficacy data is still being collected. Additionally, it is an expensive medication, and it is not covered by all insurance plans.
Overall, Mounjaro is a promising new option for weight loss, but it is important to talk to your provider to see if it is right for you.